Donald Trump: 5 questions medtech needs to ask

From tax breaks to Obamacare repeal, medtech companies are likely due to experience major changes under President Donald Trump. The situation, though, remains unpredictable. “I don’t think that there has been a scenario, not since I’ve been a professional and in politics, where we really know so little about exactly what the key priorities are

Pages: 1 2 3 4 5 6

Healthcare IT funding hits record $5.1 billion

Global funding for healthcare information technology and digital health companies hit record levels last year, according to the latest annual report from Austin, Texas–based Mercom Capital Group. There were a record 622 deals worth $5.1 billion in 2016, up from 574 deals worth $4.6 billion in 2015, according to Mercom Capital Group. The amounts involve

Global CT systems market to quadruple by 2023

The market for computed tomography (CT) systems, which are used to generate detailed images of structures inside the body, is set to rise from just under $3.6 billion in 2016 to around $12.1 billion by 2023, representing a compound annual growth rate of 18.2%, according to research and consulting firm GlobalData. The company’s latest report

B Braun inks investment, cooperative deal with Trendlines Medical Sinagpore

B. Braun said today that it inked an investment and cooperation agreement with Trendlines subsidiary Trendlines Medical Singapore, making them a minority shareholder in the company. With the investment, B Braun will hold a 20.7% stake in the company, while Trendlines holds a 79.3% stake. “This agreement with B. Braun further advances our strategic relationship

Hamilton Thorne reports 18% sales increase for the quarter ended September 30, 2016

Hamilton Thorne, a provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, reported operational and financial results for the quarter and nine months ended September 30, 2016. Sales increased 18% to $2.45 million for the quarter ended September 30, 2016 versus the prior year. Sales

B. Braun’s Aesculap puts nearly $3m into ApiFix

B. Braun’s Aesculap division today invested $2.8 million into ApiFix’s $5 million Series B financing round to help support ApiFix’s minimally invasive, non-fusion spinal implant system designed to treat adolescent idiopathic scoliosis. The ApiFix device, which won CE Mark clearance for use in the European Union in 2012, is designed to correct adolescent idiopathic scoliosis

Operating room equipment market set to hit $1.1 billion by 2023

The global operating room (OR) equipment market, which covers OR tables, OR lights and surgical boom units, is set to rise from just over $920 million in 2016 to around $1.1 billion by 2023, representing a compound annual growth rate of 2.6%, according to research and consulting firm GlobalData. The company’s latest report states that

Cohero raises $9m Series A for smart inhalers

Cohero Health said today that it closed a $9 million Series A round for its BreatheSmart patient monitoring platform, which can track medication adherence and measure lung functioning. The funds are also earmarked for commercial development efforts and expanding Cohero’s clinical trial program. The round was led by Three Leaf Ventures with participation by Zaffre Investments and BioAdvance, Cohero

Healthcare IT VC funding reaches $1.25 billion in Q3 2016 reports Mercom Capital Group

Mercom Capital Group, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Healthcare Information Technology (IT)/Digital Health sector for the third quarter of 2016. Mercom’s comprehensive report covers deals of all sizes across the globe. Venture capital (VC) funding in the Health IT sector, including

Tepha closes royalty rights buyout from Metabolix

Implantable medical device developer Tepha said today it completed a buy-out of its royalty obligations with former licensor and parent company Metabolix. The deal, which the companies announced in June, eliminates future royalties for Metabolix in exchange for $2 million. The deal also includes 2 additional Metabolix production strains and related IP, the company said.

3D printer Carbon raises $81m

Silicon Valley-based 3D printing company Carbon said today that it raised $81 million in a new funding round it plans to use for its medical device and auto part printing business. The round was led by BMW Group and joined by new investors GE Ventures, Nikon, JSR and existing backers, bringing the total raised by the company

Trumpf launches venture investment arm

Trumpf said yesterday that it launched a venture capital investment arm looking to fund tech startups effective July 1. The newly formed arm aims to invest approximately $45 million (€40 million) in “promising young companies that want to play a major role in shaping the future of industry” over the next 5 years, Trumpf said. The venture group

Private equity player Vance Street Capital acquires Motion Dynamics

Private equity player Vance Street Capital said it invested an unspecified amount in Motion Dynamics Corp. and its wire-based components business. Los Angeles-based Vance Street said Motion Dynamics is the 2nd investment out of its 2nd fund, reportedly targeted at $350 million. The 1st investment, medical device OEM A&E Medical, was announced in February. Fruitport, Mich.-based Motion Dynamics

OEMs get in on $10m Series C for biosensor maker HMicro

HMicro said today that “dominant strategic OEM partners” joined a $10.2 million Series C round for the biosensor platform it’s developing for commercialization. Fremont, Calif.-based HMicro makes “system-on-a-chip” biosensors for medical device companies. Existing backers XSeed Capital, Seraph Group and Uniquest also joined the round, the company said. “This strategic investment by new OEM partners who will

Bundled payments are the future of medtech

Bundled payments in orthopedics may not directly influence medical technology companies yet, but the smart firms are paying attention. The process will very likely soon be used in procedures beyond hip and knee, such as spine surgeries and neurosurgery, and future iterations of the program could include commercial risk-sharing. It is the future of many